IL75280A0 - Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor - Google Patents
Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used thereforInfo
- Publication number
- IL75280A0 IL75280A0 IL75280A IL7528085A IL75280A0 IL 75280 A0 IL75280 A0 IL 75280A0 IL 75280 A IL75280 A IL 75280A IL 7528085 A IL7528085 A IL 7528085A IL 75280 A0 IL75280 A0 IL 75280A0
- Authority
- IL
- Israel
- Prior art keywords
- monoclonal antibodies
- cell lines
- hybridoma cell
- human mif
- lymphokine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL91476A IL91476A0 (en) | 1984-05-24 | 1989-08-30 | Monoclonal antibodies to human macrophage migration inhibition factor(mif),its preparation and its use in the determination of human mif |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH255784 | 1984-05-24 | ||
CH378684 | 1984-08-07 | ||
CH544684 | 1984-11-14 | ||
CH51285 | 1985-02-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL75280A0 true IL75280A0 (en) | 1985-09-29 |
Family
ID=27427909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL75280A IL75280A0 (en) | 1984-05-24 | 1985-05-22 | Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0162812B1 (ja) |
JP (3) | JPH0672158B2 (ja) |
AT (1) | ATE93869T1 (ja) |
DE (1) | DE3587553D1 (ja) |
DK (1) | DK171646B1 (ja) |
ES (3) | ES8702950A1 (ja) |
IE (1) | IE60450B1 (ja) |
IL (1) | IL75280A0 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8623850D0 (en) * | 1986-10-03 | 1986-11-05 | Ciba Geigy Ag | Lymphokine related peptide |
EP0263072B1 (en) | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
WO1990011301A1 (en) * | 1989-03-17 | 1990-10-04 | Genetics Institute, Inc. | Human macrophage migration inhibitory factor |
GB8915414D0 (en) * | 1989-07-05 | 1989-08-23 | Ciba Geigy | Novel cytokines |
US5107906A (en) * | 1989-10-02 | 1992-04-28 | Swenson Paul F | System for fast-filling compressed natural gas powered vehicles |
US5149544A (en) * | 1989-11-13 | 1992-09-22 | Research Corporation Technologies, Inc. | Method of inhibiting progenitor cell proliferation |
DE69435303D1 (de) * | 1993-05-17 | 2010-09-02 | Cytokine Pharmasciences Inc | Er behandlung von krankheiten bei denen eine cytok |
US6645493B1 (en) * | 1993-05-17 | 2003-11-11 | The Picower Institute For Medical Research | Composition containing anti-MIF antibody |
US20030235584A1 (en) | 2000-02-28 | 2003-12-25 | Kloetzer William S. | Method for preparing anti-MIF antibodies |
DE10121255A1 (de) | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen |
MY140679A (en) | 2001-05-24 | 2010-01-15 | Avanir Pharmaceuticals | Inhibitors of macrohage migration inhibitory factor and methods for identifying the same |
TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
CA2600175A1 (en) | 2005-03-24 | 2006-03-20 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
CN100457895C (zh) * | 2006-05-24 | 2009-02-04 | 中国科学院生物物理研究所 | 鼠抗人巨噬细胞迁移抑制因子单克隆抗体及其应用 |
WO2013050453A1 (en) | 2011-10-07 | 2013-04-11 | Baxter Healthcare S.A. | Oxmif as a diagnostic marker |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2755363C3 (de) * | 1977-12-12 | 1983-12-01 | R & Z Biologicals Beteiligungsgesellschaft mbH, 4050 Mönchengladbach | Testverfahren zur Diagnose von Malignomen |
US4299814A (en) * | 1979-05-25 | 1981-11-10 | Monsanto Company | Radioimmunoassay of MIF |
JPS5939832A (ja) * | 1982-08-28 | 1984-03-05 | Ajinomoto Co Inc | モノクロ−ナル抗体ならびにその製法、使用法 |
DD230876A1 (de) * | 1983-05-09 | 1985-12-11 | Akad Wissenschaften Ddr | Verfahren zur gewinnung monoklonaler antikoerper gegen human-mif |
-
1985
- 1985-03-11 JP JP60046694A patent/JPH0672158B2/ja not_active Expired - Lifetime
- 1985-05-15 AT AT85810232T patent/ATE93869T1/de not_active IP Right Cessation
- 1985-05-15 EP EP85810232A patent/EP0162812B1/de not_active Expired - Lifetime
- 1985-05-15 DE DE85810232T patent/DE3587553D1/de not_active Expired - Fee Related
- 1985-05-22 ES ES543391A patent/ES8702950A1/es not_active Expired
- 1985-05-22 IL IL75280A patent/IL75280A0/xx unknown
- 1985-05-23 DK DK229985A patent/DK171646B1/da not_active IP Right Cessation
- 1985-05-23 IE IE129585A patent/IE60450B1/en not_active IP Right Cessation
-
1986
- 1986-09-16 ES ES557071A patent/ES8801852A1/es not_active Expired
- 1986-09-16 ES ES557072A patent/ES8801850A1/es not_active Expired
-
1993
- 1993-09-30 JP JP5244287A patent/JPH0780915B2/ja not_active Expired - Lifetime
-
1994
- 1994-03-14 JP JP6042201A patent/JPH07108915B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH07108915B2 (ja) | 1995-11-22 |
JPS60248617A (ja) | 1985-12-09 |
JPH06217789A (ja) | 1994-08-09 |
DK229985A (da) | 1985-11-25 |
ES8801852A1 (es) | 1988-02-16 |
IE60450B1 (en) | 1994-07-13 |
DK229985D0 (da) | 1985-05-23 |
JPH0672158B2 (ja) | 1994-09-14 |
ES543391A0 (es) | 1987-01-16 |
ATE93869T1 (de) | 1993-09-15 |
DK171646B1 (da) | 1997-03-03 |
DE3587553D1 (de) | 1993-10-07 |
EP0162812A2 (de) | 1985-11-27 |
EP0162812B1 (de) | 1993-09-01 |
EP0162812A3 (en) | 1988-04-20 |
JPH0780915B2 (ja) | 1995-08-30 |
IE851295L (en) | 1985-11-24 |
ES8702950A1 (es) | 1987-01-16 |
ES557072A0 (es) | 1987-08-01 |
ES8801850A1 (es) | 1987-08-01 |
JPH0770192A (ja) | 1995-03-14 |
ES557071A0 (es) | 1988-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75280A0 (en) | Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor | |
Van Damme et al. | Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6. | |
Van Damme et al. | Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. | |
NO165556C (no) | Monoklonale antistoff samt derivater derav med hoey affinitet til human-renin og sturkturelt lignende renin for in vitro anvendelse. | |
Koyasu et al. | Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone. | |
DK113389A (da) | Monoklonale antistoffer | |
ATE245699T1 (de) | Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie | |
Chen et al. | Production of osteoclast‐activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes | |
DK118682A (da) | Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf | |
DE3855747D1 (de) | Biologische materialien, deren herstellung und verwendung in der therapie | |
AU608216B2 (en) | Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies | |
Hardwicke et al. | Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods | |
Köck et al. | Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1. | |
Kishimoto et al. | Polymorphism of submandibular-sublingual salivary proteins which promote adhesion of Streptococcus mutans serotype-c strains to hydroxyapatite | |
Knudsen et al. | Elevated intracellular cAMP levels inhibit interleukin-1 production by the tumour cell line U937 | |
Nishihara et al. | Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide | |
Larsson et al. | Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes | |
Van Damme et al. | IDENTIFICATION OF THE HUMAN 26-kD PROTEIN, INTERFERON 02 (IFN-N2), AS AB CELL HYBRIDOMA/PLASMACYTOMA GROWTH FACTOR INDUCED BY INTERLEUKIN 1 AND TUMOR NECROSIS FACTOR | |
ATE229983T1 (de) | Maspin- ein neues serpin mit tumor unterdrückender aktivität | |
DE19529026C2 (de) | Monoklonale Antikörper gegen humanes Interleukin-10 | |
Kull Jr et al. | Macrophage cytotoxin: Sources and mechanism | |
FR2587035B1 (fr) | Procede de production d'ethanol par fermentation de milieux sucres | |
JPH02282399A (ja) | リンホカイン saf | |
HUT34547A (en) | Process for the purification of proteins isolated from microbe cultures | |
Lachman | Monoclonal antibody to human IL 1 and hybrid cell lines secreting IL 1 |